|
HS Code |
551620 |
| Chemical Name | 4-Bromo-2-Methylphenyl Isocyanate |
| Molecular Formula | C8H6BrNO |
| Molecular Weight | 212.05 g/mol |
| Cas Number | 42751-79-9 |
| Appearance | Colorless to pale yellow liquid |
| Boiling Point | 120-125°C at 17 mmHg |
| Purity | Typically ≥97% |
| Density | 1.56 g/cm³ |
| Solubility | Reacts with water; soluble in organic solvents |
As an accredited 4-Bromo-2-Methylphenyl Isocyanate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A 25-gram amber glass bottle with a sealed cap, labeled “4-Bromo-2-Methylphenyl Isocyanate,” includes hazard and handling warnings. |
| Shipping | 4-Bromo-2-Methylphenyl Isocyanate is shipped in tightly sealed containers, protected from moisture and direct sunlight. The chemical is classified as hazardous and should be handled according to proper safety regulations, including the use of appropriate labeling and documentation. Transport is typically by ground or air, following all applicable chemical shipping guidelines. |
| Storage | 4-Bromo-2-Methylphenyl Isocyanate should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area, away from moisture, heat, and incompatible substances such as strong acids, bases, and oxidizers. Protect from light and sources of ignition. Use only non-sparking tools and keep container protected from physical damage. Store under inert atmosphere if possible. |
Applications of 4-Bromo-2-Methylphenyl Isocyanate in Industrial Manufacturing4-Bromo-2-Methylphenyl Isocyanate serves as a specialized intermediate in sectors where precision, controlled reactivity, and strict compliance drive production efficiency and product reliability. As a manufacturer, we supply this material for integration in processes where consistent purity and reliable batch performance are essential to downstream product quality and regulatory acceptance. 1. Pharmaceutical Intermediate SynthesisPharmaceutical manufacturers employ this compound as an isocyanate donor in the assembly of advanced drug intermediates, particularly for molecules requiring selective functionalization on bromo-phenyl rings. Formulators use this input during the synthesis of urea and carbamate derivatives under anhydrous, inert conditions, with rigorous in-process monitoring. The input ratio and reactivity profile allow chemists to streamline step economy, reducing purification burdens in regulatory-driven environments such as GMP API production. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical SynthesisIn agricultural chemical manufacturing, formulators utilize this isocyanate to construct heterocyclic scaffolds with incorporated brominated moieties, directly affecting target specificity in insecticide or fungicide actives. The bromo-phenyl group brings electronic modulation, enabling structural tuning in SAR (structure–activity relationship) optimization. Standard process control requires precise isocyanate addition under basic or catalytic conditions, with rigorous residue removal for regulatory shipment. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Polymer and Polyurethane Component ManufacturingChemical engineers apply this compound as a functional isocyanate for polymer chain extension or crosslinking during specialty construction of polyurethanes, polyureas, and advanced block copolymers. Its brominated aromatic ring can confer flame retardancy or chemical resistance. Precise measurement of NCO content controls reactivity with polyols or diamine components during process stages such as prepolymer preparation or batch blending. End users request traceability documentation and residual monomer testing for each lot supplied. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Organic Electronic and LCD Material ProductionManufacturers in the electronics segment invest this isocyanate as a building block for high-performance organic materials used in display technology. Its specific substitution pattern enables tuning of charge transport in organic semiconductors and alignment layers for liquid crystals. Purity and impurity profile play critical roles, necessitating batch traceability and particle-free supply for customers working in cleanrooms. Synthesis of downstream materials often proceeds via nucleophilic addition or controlled stepwise polymerization to obtain photoactive films and alignment coatings. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Fine Chemical and Specialty Intermediate SegmentChemical synthesis companies select this isocyanate to prepare specialized fine chemical intermediates, especially for research or small-scale custom molecules involving halogenated aromatic frameworks. The product’s reactivity profile supports the production of robust linkers, cross-coupling precursors, and diagnostics reagents. Producers require flexible batch sizes and consistent purity aligned with analytical method validation for downstream use. Small-molecule R&D facilities value speed and reproducibility when the material operates in key steps to introduce isocyanate-derived functionalities. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Bromo-2-Methylphenyl Isocyanate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Years of hands-on production shape how we see 4-Bromo-2-Methylphenyl Isocyanate. Every batch starts with raw materials scrutinized for purity, and we monitor impurities at each distillation and crystallization step. Hydration levels and contaminant controls push us to fine-tune every parameter, not just for the numbers, but because downstream users count on guaranteed reactions. In this business, the real test comes after shipment; if a batch doesn’t work for a customer, we hear about it and adjust our process. Direct relationships with pharmaceutical process chemists and polymer teams taught us the true value: aromatic isocyanates aren’t all the same, and the smallest tweak during synthesis changes the result in the next application—pharma, agrochemical, or advanced polymer.
Any seasoned chemist knows the value of a well-defined aromatic isocyanate. 4-Bromo-2-Methylphenyl Isocyanate has earned a dedicated following among custom synthesis labs and pilot plants, mostly because of its clean reactivity. The ortho-methyl group and para-bromo substituent carve out a profile not easily matched by standard phenyl isocyanates. Where templates like 4-Bromophenyl Isocyanate drag along uncontrolled polymerization or impurity chains, the methyl adjustment creates a noticeably more manageable, crystalline material with reduced volatility. Our process leverages those structural subtleties—less waste in each batch, more reproducibility for the customer. Products like this don’t evolve by chance. They adapt to the needs of scale-up, regulatory changes, and emerging synthetic methodologies.
Every specification on our COA comes from multiple independent readings, not just because a standard demands it, but because real-world activity swings on the tail of a tenth of a percent off-target. We manufacture 4-Bromo-2-Methylphenyl Isocyanate with high minimum isocyanate content and strict controls on moisture, achieved through vacuum stripping and inert gas handling. The result gives consistently sharp melting points, narrow color ranges, and no extraneous halogen contamination. We’ve tested performance both in-house and through customer pilot syntheses: less exotherm in urea formation, cleaner carbamate couplings, and greater selectivity in di-substituted aromatic applications.
That reliability doesn’t come by declaring a shelf life. It comes from cycling through failed runs, cross-comparing IR and NMR with every new change in catalyst, and tracking each intermediate’s stability for months at a time. We don’t settle when an analysis looks a little off; we investigate until we know why. Customers have often told us they only see full conversion in downstream steps with our material, after switching away from less-controlled imports.
A lot of isocyanates look similar on paper, but anyone who’s scaled a reaction to multi-kilogram lots can tell you the surprises don’t show in a supplier’s catalog. We stick to protocols that ensure minimal residual bromine, low potassium, and no traces of chlorinated side products. The reason isn’t cosmetic: in coupling chemistry, especially with complex nucleophiles, even minor impurities trigger unexpected polymerization or color development. We’ve traced downstream costs to missed filtration or a skipped dry cycle at the supplier stage. Responsibly made 4-Bromo-2-Methylphenyl Isocyanate pays back every lab that pushes their yields higher, spends less time on column cleaning, and avoids the need for laborious recrystallization.
Our approach always tailors to chemists’ input. Many researchers share feedback about which solvents they find effective for this isocyanate’s dissolution, about which batch-to-batch variables disrupt their scale-ups, and about which reactivity limitations hurt them most—feedback we actively seek before changing any process parameter. We’re not remote from our users’ results; we’re accountable when their analytics say something’s off.
Chemists facing tough transformation challenges turn to this compound for reasons rooted in years of synthetic history. The para-bromo position opens up unique halogen coupling options, while the ortho-methyl group blocks certain unwanted side reactions. Off-the-shelf isocyanates like phenyl or p-tolyl forms may fit basic needs, but don’t offer the same precision in directed aromatic substitution. Experienced process developers know that. These differences appear most clearly in stepwise insertions, especially when forming bioactive heterocycles or advanced polymers.
4-Bromo-2-Methylphenyl Isocyanate stands out during synthesis of ureas, carbamates, and cyclic peptides. The compound’s predictable kinetics let development teams cut troubleshooting cycles, saving both solvent and manpower. Crops science and pharmaceutical intermediates see even greater gains—one customer moved from four purification steps to two after using our isocyanate, simply by avoiding contamination from poorly characterized alternatives. Direct experience, both from our own labs and feedback from the field, drives continuous improvement.
No one spends as much time with this isocyanate as the workers producing it. The handling knowledge comes not just from MSDS sheets but from solving real, everyday challenges. Reliable isocyanate production depends on total exclusion of atmospheric moisture. Every batch seals under dry nitrogen or argon, and temperature controls always run 24/7—they don’t just follow a written SOP, they follow lessons learned from past leaks and lost material. Consultants may quote generalist advice, but only a manufacturing background exposes the quirks: for example, a persistent tendency for solidification in transfer lines below 18°C, or the detail that the bromo-substituent brings a distinct, harsh odor which aids—but doesn’t replace—good leak detection.
End users who visit our facility see safety at the point of action. Operators rely on real-time isocyanate detection and personal VOC meters, and the production floor builds in high-performance ventilation at every transfer and blending station. Over years, we’ve learned to minimize exposure by doubling glove barriers and demanding single-use PPE for every transfer. Problems solved at the plant level—like container design tweaks to limit spillage or the adjustment of dosing rates to moderate exotherm—deliver value when the product reaches a lab bench or pilot reactor anywhere in the world.
Pharmaceutical chemists scout specialty isocyanates as building blocks for active molecules and novel intermediates. Our 4-Bromo-2-Methylphenyl Isocyanate quickly found favor across medicinal chemistry platforms. The strong electron-withdrawing power of the bromo group, coupled with the methyl’s steric influence, delivers reactivity patterns beneficial in both small-molecule and macrocycle synthesis. Medicinal teams exploit the isocyanate’s ability to form stable ureas and carbamates under mild conditions, getting higher yields and reduced byproduct formation compared to bulk commercial isocyanates.
We’ve also watched the momentum this product gathers in the agrochemical sector. The custom development of herbicide and fungicide candidates often depends on access to halogenated isocyanates with narrow impurity profiles. Customers come to us after facing run-to-run failures with less regulated imports, focusing instead on consistent conversion rates and tight analytical margins. Polymers research teams see similar benefits. Their copolymerizations run cleaner and more predictably, especially when targeting specialty endgroups that fail in the presence of persistent metal catalyst residues. Feedback from these sectors pushed us to refine purification, minimize halogen cross-contamination, and track downstream environmental markers.
A persistent challenge in isocyanate manufacturing comes from tightening regulations on emissions, workplace exposure, and product traceability. Rather than struggle against this trend, we designed our operations with control points at every cycle—integrating sealed filtration units, continuous moisture analysis, and direct monitoring of effluent streams. These investments pay returns, not just in regulatory compliance, but in direct benefits for researchers counting on product repeatability.
We live with the risks and rewards of every process improvement. Years ago, uncontrolled environmental release or off-gassing in storage would endanger our workers and compromise batch integrity. Now, vented containment, monitored airlocks, and data-driven QC cut those risks. The learning curve stays steep, and not every process change works as planned. Our operators work close to the chemistry—flagging color shifts and subtle viscosity changes, catching pressure anomalies long before instrumentation registers a drift. These are the unspoken efforts behind consistent, safe isocyanate delivery.
We don’t view ourselves solely as suppliers; our whole team sees each lot as a reflection on our reputation. Analysis runs by HPLC, MS, and NMR cover every finished batch, not just the occasional random pick. Customers use that information to validate scale-ups, and we don’t cut corners on documentation. Each run receives a full digital chain of custody, from in-process sampling to output, supporting everything from patent filings to final product regulatory dossiers. Companies depending on repeatable process chemistry for FDA submissions or environmental filings rely directly on our attention to detail.
Practicality drove every manufacturing tweak we made. Every out-of-specification event triggered a full root-cause review. We responded with equipment upgrades, alternative purification routes, or better-trained personnel. Nothing in the process escapes scrutiny. Real results—zero unplanned shutdowns in eighteen months, fall-below-thresholds for heavy metals, and countless hours saved in our customers’ quality control cycles—justify the premium some clients pay over commoditized materials. We encourage regular, open feedback from all end users, revising procedures and documentation according to actual lab experience, not simply internal preference.
We know developing a new process or launching a new product is never routine. Researchers and plant leaders come up against shifting reagent performance all the time. Our approach never treats feedback as administrative; it becomes the driver for new purification systems, updated packaging methods, or improved logistic protocols. A recent example: During a hazardous materials audit at a major pharmaceutical plant partner, they flagged specific packaging failures which occasionally let moisture seep in. Within one quarter, we re-designed our container seal systems, switching to multilayer foil liners with integrated desiccant pouches. Customer retesting cut moisture ingress incidents down by 96%, improving both shelf stability and in-lab performance. This iterative improvement only comes from genuine manufacturer–user relationships.
Transparency builds trust, especially during incident resolution. On more than one occasion, a process chemist’s unexpected yield drop or impurity spike led us to retrace the entire batch history, identify process deviations, and—where warranted—replace product before costly downstream failures accumulated. Open collaboration solves real problems. By understanding each customer’s context—whether small-batch drug discovery, bulk agrochemical production, or high-purity materials research—we continue honing not just the isocyanate molecule, but every facet of its preparation, handling, and shipment.
While the chemical market crowds with intermediaries and repackagers, true manufacturers do the heavy lifting that transforms a synthetic proposal into a working, batch-scaled product. Our knowledge of 4-Bromo-2-Methylphenyl Isocyanate means more than making the same formula each time—it means guaranteeing that what leaves our doors meets the changing needs of frontline research and commercial production, day in and day out. The sector thrives only when manufacturers close the loop with users, tracking every batch, every lesson, and every adjustment. We learn each time a reaction runs smoother, each time a customer calls with an unexpected result, and each time our quality team pinpoints and corrects the smallest deviation from the target.
This hands-on, feedback-driven cycle produces far more than a catalog chemical. It results in a specialty product that grows and adapts with the best minds in synthesis, innovative thinking, and applied research. We commit to ongoing investment in analytical science, smarter packaging, and tighter safety controls. We hold ourselves accountable to the highest standards—not as a matter of compliance, or empty slogans, but because our experience shows the real costs of compromise, and the real rewards of partnership built on technical excellence and direct communication.